| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/17/2007 | EP1742967A2 Preparation of scfv antibody fragments |
| 01/17/2007 | EP1742966A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 01/17/2007 | EP1742965A2 Treatments for pancreatic cancer |
| 01/17/2007 | EP1742660A2 Treatment of disorders |
| 01/17/2007 | EP1742654A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 01/17/2007 | EP1432445B1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 01/17/2007 | EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation |
| 01/17/2007 | EP1340088B1 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1131430B1 Mitogenic regulators |
| 01/17/2007 | EP0687272B1 Method and compositions for recombinant osteogenic protein production |
| 01/17/2007 | CN1898384A Msp-3-like family of genes |
| 01/17/2007 | CN1898383A Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 01/17/2007 | CN1898268A Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 01/17/2007 | CN1898267A 修饰的抗cd52抗体 Modified anti-cd52 antibody |
| 01/17/2007 | CN1898266A Removal of high molecular weight aggregates using hydroxyapatite chromatography |
| 01/17/2007 | CN1898265A Purification of immunoglobulins |
| 01/17/2007 | CN1898264A Novel anti-il 13 antibodies for treating cancer |
| 01/17/2007 | CN1898262A Il-7 fusion proteins |
| 01/17/2007 | CN1898260A Peptides with anti-obesity activity and other related uses |
| 01/17/2007 | CN1897971A Cd40 antibody formulation and methods |
| 01/17/2007 | CN1897970A Specific human antibodies |
| 01/17/2007 | CN1897966A Therapeutic regimens for baff antagonists |
| 01/17/2007 | CN1896229A Production of anti-CD20 intrinsic antibody and its use |
| 01/17/2007 | CN1896102A Anti-hbs monoclonal antibodies |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof |
| 01/16/2007 | US7163806 mammalian therapeutics free from prion contamination |
| 01/16/2007 | US7163797 50 human secreted proteins |
| 01/16/2007 | US7163793 Preparing immunoglobulins for use as tools in prevention of DNA and RNA degradation during molecular analysis; enzyme inhibitors |
| 01/16/2007 | US7163683 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 01/16/2007 | US7163682 For inducing antibody production against Streptococcal antigens |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | US7163680 Contacting vascular endothelial cells proximate to cancerous cells with the biological agent to permit both binding of biological agent to vascular endothelial cells proximate to cancerous cells and ablating or killing of cancerous cells |
| 01/16/2007 | CA2168963C Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 01/11/2007 | WO2007005955A2 Anti-il-23 antibodies, compositions, methods and uses |
| 01/11/2007 | WO2007005874A2 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 01/11/2007 | WO2007005715A2 Staphylococcal antibodies which cross-react with fungal antigens |
| 01/11/2007 | WO2007005605A2 Phosphospecific chemokine receptor antibodies |
| 01/11/2007 | WO2007004748A1 Nucleic acid capable of binding to immunoglobulin g and use thereof |
| 01/11/2007 | WO2007004325A1 Protein preparation containing s1-5 |
| 01/11/2007 | WO2007003090A1 A composition instead of positive sera used as control in diagnostic agent and its application |
| 01/11/2007 | WO2007003041A1 Methods of isolating cells and generating monoclonal antibodies |
| 01/11/2007 | WO2006120455A3 Ovalbumin promoter constructs for retroviral vectors |
| 01/11/2007 | WO2006107945A3 Use of rip in treating staphylococcus aureus infections |
| 01/11/2007 | WO2006106341A3 Sheep primers |
| 01/11/2007 | WO2006105062A3 Altered antibody fc regions and uses thereof |
| 01/11/2007 | WO2006096710A3 Detection, imaging, and depletion of chlamydia |
| 01/11/2007 | WO2006089114A3 Methods and compositions for treating an anthrax toxin mediated condition |
| 01/11/2007 | WO2006083936A3 Anti-ephb2 antibodies and methods using same |
| 01/11/2007 | WO2006061259A3 Cytotoxic agents comprising new c-2 modified taxanes |
| 01/11/2007 | WO2006061219A3 Il-7 variants with reduced immunogenicity |
| 01/11/2007 | WO2006026601A3 Homogeneous enzyme immunoassay for oral fluid |
| 01/11/2007 | WO2005124358A3 Diagnosis and treatment of siglec-6 associated diseases |
| 01/11/2007 | WO2003083057A3 Adipocytes and uses thereof |
| 01/11/2007 | US20070010661 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010448 Drug targets in Candida albicans |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010433 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070010029 Protein biopolymer markers predictive of insulin resistance |
| 01/11/2007 | US20070010009 Antibody Composition-Producing Cell |
| 01/11/2007 | US20070009987 recombinant fusion protein comprising binding domain antibody that binds to cell-surface antigen, functional group domain for eliciting desired effect on target molecule, extension peptide between binding domain and functional group domain containing uncoupled cysteine residue capable of forming s-s bond |
| 01/11/2007 | US20070009975 incubating a sample from humans with monoclonal antibodies or fragments, that specifically binds epitopes of campylobacter antigens, then detecting the formation of antigen-antibody complexes which is indicative of an infection of campylobacter |
| 01/11/2007 | US20070009972 Epidermal growth factor receptor polypeptides and antibodies |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009964 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells |
| 01/11/2007 | US20070009963 Apolipoprotein biopolymer marker indicative of normal human |
| 01/11/2007 | US20070009959 Methods for producing antibodies |
| 01/11/2007 | US20070009957 Vectors used to create hybrid constant regions |
| 01/11/2007 | US20070009955 Secreted polypeptide species associated with cardiovascular disorders |
| 01/11/2007 | US20070009952 detecting susceptibility for basement membrane disease such as congenital nephrotic syndromes of the Finnish type (NPHS1); proteinuria; detecting the presence or absence of a mutation in the coding region of the gene for NPHS1 |
| 01/11/2007 | US20070009950 Methods and compositions for vitamin K epoxide reductase |
| 01/11/2007 | US20070009941 Complementary DNAs |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009931 Negative correlation between IRP-2 and Transferrin receptor expression as a diagnostic of Alzheimer's disease |
| 01/11/2007 | US20070009919 Detecting DNA damage by identifying the activation state of Ataxia Telangiectasia-Mutated kinase by determining the phosphorylation state of a specific serine residue; antibodies that recognize the phosphorylation state; drug screening for ATM kinase agonists |
| 01/11/2007 | US20070009916 Guanosine triphosphate-binding protein coupled receptors |
| 01/11/2007 | US20070009888 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 01/11/2007 | US20070009886 Carbohydrate-associated proteins |
| 01/11/2007 | US20070009885 Methods and compositions for the detection of cervical disease |
| 01/11/2007 | US20070009569 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance |
| 01/11/2007 | US20070009551 Aids ancestral viruses and vaccines |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009543 Protein involved in ovarian cancer |
| 01/11/2007 | US20070009541 Drug conjugate composition |
| 01/11/2007 | US20070009540 Drug conjugate composition |
| 01/11/2007 | US20070009539 a liquid and/or lyophilized mixture of buffers and humanized antibody that binds tumor antigens, chemically coupled to a maytansine derivative, used as antitumor and/or anticarcinogenic agents |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009537 Antimicrobial activity of antibodies producing reactive oxygen species |
| 01/11/2007 | US20070009536 Novel MAdCAM antibodies |
| 01/11/2007 | US20070009528 Antibodies to masp-2 |
| 01/11/2007 | US20070009527 Method for cloning of variable domain sequences |
| 01/11/2007 | US20070009526 Anti-IL-23 antibodies, compositions, methods and uses |